世界の壊死性皮膚感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Necrotizing Skin infections Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4047 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、壊死性皮膚感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、抗生物質）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・壊死性皮膚感染症治療の市場動向 ・企業の競争状況、市場シェア ・壊死性皮膚感染症治療の種類別市場規模（手術、抗生物質） ・壊死性皮膚感染症治療の用途別市場規模（病院、診療所、外来手術センター、その他） ・壊死性皮膚感染症治療の北米市場規模2016-2027（アメリカ、カナダ） ・壊死性皮膚感染症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・壊死性皮膚感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・壊死性皮膚感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・壊死性皮膚感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Actavis (Durata Therapeutics)、Merck (Cubist Pharmaceutical)、Wockhardt、Atox Bio、Basilea Pharmaceutical、Melinta Therapeutics） ・結論

Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly called as “Flesh eating disease”. Necrotizing skin infections penetrates deeper layers of soft tissues and rapidly spreads along facial planes.
The global market for necrotizing skin infection treatment is expected to register a moderate growth rate over the forecast period on the account of increase in number of diagnostic tests performed in humans.

Market Analysis and Insights: Global Necrotizing Skin infections Treatment Market
The global Necrotizing Skin infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Necrotizing Skin infections Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Necrotizing Skin infections Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Necrotizing Skin infections Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Necrotizing Skin infections Treatment market.

Global Necrotizing Skin infections Treatment Scope and Market Size
Necrotizing Skin infections Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Necrotizing Skin infections Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Antibiotics

Segment by Application
Hospitals
Clinics
Ambulatory Surgery Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Actavis (Durata Therapeutics)
Merck (Cubist Pharmaceutical)
Wockhardt
Atox Bio
Basilea Pharmaceutical
Melinta Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Necrotizing Skin infections Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Antibiotics
1.3 Market by Application
1.3.1 Global Necrotizing Skin infections Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Necrotizing Skin infections Treatment Market Perspective (2016-2027)
2.2 Necrotizing Skin infections Treatment Growth Trends by Regions
2.2.1 Necrotizing Skin infections Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Necrotizing Skin infections Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Necrotizing Skin infections Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Necrotizing Skin infections Treatment Industry Dynamic
2.3.1 Necrotizing Skin infections Treatment Market Trends
2.3.2 Necrotizing Skin infections Treatment Market Drivers
2.3.3 Necrotizing Skin infections Treatment Market Challenges
2.3.4 Necrotizing Skin infections Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Necrotizing Skin infections Treatment Players by Revenue
3.1.1 Global Top Necrotizing Skin infections Treatment Players by Revenue (2016-2021)
3.1.2 Global Necrotizing Skin infections Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Necrotizing Skin infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Necrotizing Skin infections Treatment Revenue
3.4 Global Necrotizing Skin infections Treatment Market Concentration Ratio
3.4.1 Global Necrotizing Skin infections Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Necrotizing Skin infections Treatment Revenue in 2020
3.5 Necrotizing Skin infections Treatment Key Players Head office and Area Served
3.6 Key Players Necrotizing Skin infections Treatment Product Solution and Service
3.7 Date of Enter into Necrotizing Skin infections Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Necrotizing Skin infections Treatment Breakdown Data by Type
4.1 Global Necrotizing Skin infections Treatment Historic Market Size by Type (2016-2021)
4.2 Global Necrotizing Skin infections Treatment Forecasted Market Size by Type (2022-2027)

5 Necrotizing Skin infections Treatment Breakdown Data by Application
5.1 Global Necrotizing Skin infections Treatment Historic Market Size by Application (2016-2021)
5.2 Global Necrotizing Skin infections Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Necrotizing Skin infections Treatment Market Size (2016-2027)
6.2 North America Necrotizing Skin infections Treatment Market Size by Type
6.2.1 North America Necrotizing Skin infections Treatment Market Size by Type (2016-2021)
6.2.2 North America Necrotizing Skin infections Treatment Market Size by Type (2022-2027)
6.2.3 North America Necrotizing Skin infections Treatment Market Size by Type (2016-2027)
6.3 North America Necrotizing Skin infections Treatment Market Size by Application
6.3.1 North America Necrotizing Skin infections Treatment Market Size by Application (2016-2021)
6.3.2 North America Necrotizing Skin infections Treatment Market Size by Application (2022-2027)
6.3.3 North America Necrotizing Skin infections Treatment Market Size by Application (2016-2027)
6.4 North America Necrotizing Skin infections Treatment Market Size by Country
6.4.1 North America Necrotizing Skin infections Treatment Market Size by Country (2016-2021)
6.4.2 North America Necrotizing Skin infections Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Necrotizing Skin infections Treatment Market Size (2016-2027)
7.2 Europe Necrotizing Skin infections Treatment Market Size by Type
7.2.1 Europe Necrotizing Skin infections Treatment Market Size by Type (2016-2021)
7.2.2 Europe Necrotizing Skin infections Treatment Market Size by Type (2022-2027)
7.2.3 Europe Necrotizing Skin infections Treatment Market Size by Type (2016-2027)
7.3 Europe Necrotizing Skin infections Treatment Market Size by Application
7.3.1 Europe Necrotizing Skin infections Treatment Market Size by Application (2016-2021)
7.3.2 Europe Necrotizing Skin infections Treatment Market Size by Application (2022-2027)
7.3.3 Europe Necrotizing Skin infections Treatment Market Size by Application (2016-2027)
7.4 Europe Necrotizing Skin infections Treatment Market Size by Country
7.4.1 Europe Necrotizing Skin infections Treatment Market Size by Country (2016-2021)
7.4.2 Europe Necrotizing Skin infections Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Necrotizing Skin infections Treatment Market Size (2016-2027)
8.2 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Type
8.2.1 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Application
8.3.1 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Region
8.4.1 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Necrotizing Skin infections Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Necrotizing Skin infections Treatment Market Size (2016-2027)
9.2 Latin America Necrotizing Skin infections Treatment Market Size by Type
9.2.1 Latin America Necrotizing Skin infections Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Necrotizing Skin infections Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Necrotizing Skin infections Treatment Market Size by Type (2016-2027)
9.3 Latin America Necrotizing Skin infections Treatment Market Size by Application
9.3.1 Latin America Necrotizing Skin infections Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Necrotizing Skin infections Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Necrotizing Skin infections Treatment Market Size by Application (2016-2027)
9.4 Latin America Necrotizing Skin infections Treatment Market Size by Country
9.4.1 Latin America Necrotizing Skin infections Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Necrotizing Skin infections Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Necrotizing Skin infections Treatment Market Size (2016-2027)
10.2 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Type
10.2.1 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Application
10.3.1 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Country
10.4.1 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Necrotizing Skin infections Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Actavis (Durata Therapeutics)
11.1.1 Actavis (Durata Therapeutics) Company Details
11.1.2 Actavis (Durata Therapeutics) Business Overview
11.1.3 Actavis (Durata Therapeutics) Necrotizing Skin infections Treatment Introduction
11.1.4 Actavis (Durata Therapeutics) Revenue in Necrotizing Skin infections Treatment Business (2016-2021)
11.1.5 Actavis (Durata Therapeutics) Recent Development
11.2 Merck (Cubist Pharmaceutical)
11.2.1 Merck (Cubist Pharmaceutical) Company Details
11.2.2 Merck (Cubist Pharmaceutical) Business Overview
11.2.3 Merck (Cubist Pharmaceutical) Necrotizing Skin infections Treatment Introduction
11.2.4 Merck (Cubist Pharmaceutical) Revenue in Necrotizing Skin infections Treatment Business (2016-2021)
11.2.5 Merck (Cubist Pharmaceutical) Recent Development
11.3 Wockhardt
11.3.1 Wockhardt Company Details
11.3.2 Wockhardt Business Overview
11.3.3 Wockhardt Necrotizing Skin infections Treatment Introduction
11.3.4 Wockhardt Revenue in Necrotizing Skin infections Treatment Business (2016-2021)
11.3.5 Wockhardt Recent Development
11.4 Atox Bio
11.4.1 Atox Bio Company Details
11.4.2 Atox Bio Business Overview
11.4.3 Atox Bio Necrotizing Skin infections Treatment Introduction
11.4.4 Atox Bio Revenue in Necrotizing Skin infections Treatment Business (2016-2021)
11.4.5 Atox Bio Recent Development
11.5 Basilea Pharmaceutical
11.5.1 Basilea Pharmaceutical Company Details
11.5.2 Basilea Pharmaceutical Business Overview
11.5.3 Basilea Pharmaceutical Necrotizing Skin infections Treatment Introduction
11.5.4 Basilea Pharmaceutical Revenue in Necrotizing Skin infections Treatment Business (2016-2021)
11.5.5 Basilea Pharmaceutical Recent Development
11.6 Melinta Therapeutics
11.6.1 Melinta Therapeutics Company Details
11.6.2 Melinta Therapeutics Business Overview
11.6.3 Melinta Therapeutics Necrotizing Skin infections Treatment Introduction
11.6.4 Melinta Therapeutics Revenue in Necrotizing Skin infections Treatment Business (2016-2021)
11.6.5 Melinta Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Necrotizing Skin infections Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Antibiotics
Table 4. Global Necrotizing Skin infections Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Necrotizing Skin infections Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Necrotizing Skin infections Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Necrotizing Skin infections Treatment Market Share by Regions (2016-2021)
Table 8. Global Necrotizing Skin infections Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Necrotizing Skin infections Treatment Market Share by Regions (2022-2027)
Table 10. Necrotizing Skin infections Treatment Market Trends
Table 11. Necrotizing Skin infections Treatment Market Drivers
Table 12. Necrotizing Skin infections Treatment Market Challenges
Table 13. Necrotizing Skin infections Treatment Market Restraints
Table 14. Global Necrotizing Skin infections Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Necrotizing Skin infections Treatment Market Share by Players (2016-2021)
Table 16. Global Top Necrotizing Skin infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Skin infections Treatment as of 2020)
Table 17. Ranking of Global Top Necrotizing Skin infections Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Necrotizing Skin infections Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Necrotizing Skin infections Treatment Product Solution and Service
Table 21. Date of Enter into Necrotizing Skin infections Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Necrotizing Skin infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Necrotizing Skin infections Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Necrotizing Skin infections Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Necrotizing Skin infections Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Necrotizing Skin infections Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Necrotizing Skin infections Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Necrotizing Skin infections Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Necrotizing Skin infections Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Necrotizing Skin infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Necrotizing Skin infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Necrotizing Skin infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Necrotizing Skin infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Necrotizing Skin infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Necrotizing Skin infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Necrotizing Skin infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Necrotizing Skin infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Necrotizing Skin infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Necrotizing Skin infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Necrotizing Skin infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Necrotizing Skin infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Necrotizing Skin infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Necrotizing Skin infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Necrotizing Skin infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Necrotizing Skin infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Necrotizing Skin infections Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Necrotizing Skin infections Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Necrotizing Skin infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Necrotizing Skin infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Necrotizing Skin infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Necrotizing Skin infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Necrotizing Skin infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Necrotizing Skin infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Necrotizing Skin infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Necrotizing Skin infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Necrotizing Skin infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Necrotizing Skin infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Necrotizing Skin infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Necrotizing Skin infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Actavis (Durata Therapeutics) Company Details
Table 62. Actavis (Durata Therapeutics) Business Overview
Table 63. Actavis (Durata Therapeutics) Necrotizing Skin infections Treatment Product
Table 64. Actavis (Durata Therapeutics) Revenue in Necrotizing Skin infections Treatment Business (2016-2021) & (US$ Million)
Table 65. Actavis (Durata Therapeutics) Recent Development
Table 66. Merck (Cubist Pharmaceutical) Company Details
Table 67. Merck (Cubist Pharmaceutical) Business Overview
Table 68. Merck (Cubist Pharmaceutical) Necrotizing Skin infections Treatment Product
Table 69. Merck (Cubist Pharmaceutical) Revenue in Necrotizing Skin infections Treatment Business (2016-2021) & (US$ Million)
Table 70. Merck (Cubist Pharmaceutical) Recent Development
Table 71. Wockhardt Company Details
Table 72. Wockhardt Business Overview
Table 73. Wockhardt Necrotizing Skin infections Treatment Product
Table 74. Wockhardt Revenue in Necrotizing Skin infections Treatment Business (2016-2021) & (US$ Million)
Table 75. Wockhardt Recent Development
Table 76. Atox Bio Company Details
Table 77. Atox Bio Business Overview
Table 78. Atox Bio Necrotizing Skin infections Treatment Product
Table 79. Atox Bio Revenue in Necrotizing Skin infections Treatment Business (2016-2021) & (US$ Million)
Table 80. Atox Bio Recent Development
Table 81. Basilea Pharmaceutical Company Details
Table 82. Basilea Pharmaceutical Business Overview
Table 83. Basilea Pharmaceutical Necrotizing Skin infections Treatment Product
Table 84. Basilea Pharmaceutical Revenue in Necrotizing Skin infections Treatment Business (2016-2021) & (US$ Million)
Table 85. Basilea Pharmaceutical Recent Development
Table 86. Melinta Therapeutics Company Details
Table 87. Melinta Therapeutics Business Overview
Table 88. Melinta Therapeutics Necrotizing Skin infections Treatment Product
Table 89. Melinta Therapeutics Revenue in Necrotizing Skin infections Treatment Business (2016-2021) & (US$ Million)
Table 90. Melinta Therapeutics Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Necrotizing Skin infections Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Antibiotics Features
Figure 4. Global Necrotizing Skin infections Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgery Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Necrotizing Skin infections Treatment Report Years Considered
Figure 10. Global Necrotizing Skin infections Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Necrotizing Skin infections Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Necrotizing Skin infections Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Necrotizing Skin infections Treatment Market Share by Regions (2022-2027)
Figure 14. Global Necrotizing Skin infections Treatment Market Share by Players in 2020
Figure 15. Global Top Necrotizing Skin infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Skin infections Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Necrotizing Skin infections Treatment Revenue in 2020
Figure 17. Global Necrotizing Skin infections Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Necrotizing Skin infections Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Necrotizing Skin infections Treatment Market Share by Type (2016-2027)
Figure 21. North America Necrotizing Skin infections Treatment Market Share by Application (2016-2027)
Figure 22. North America Necrotizing Skin infections Treatment Market Share by Country (2016-2027)
Figure 23. United States Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Necrotizing Skin infections Treatment Market Share by Type (2016-2027)
Figure 27. Europe Necrotizing Skin infections Treatment Market Share by Application (2016-2027)
Figure 28. Europe Necrotizing Skin infections Treatment Market Share by Country (2016-2027)
Figure 29. Germany Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Necrotizing Skin infections Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Necrotizing Skin infections Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Necrotizing Skin infections Treatment Market Share by Region (2016-2027)
Figure 39. China Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Necrotizing Skin infections Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Necrotizing Skin infections Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Necrotizing Skin infections Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Necrotizing Skin infections Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Necrotizing Skin infections Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Necrotizing Skin infections Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Necrotizing Skin infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Actavis (Durata Therapeutics) Revenue Growth Rate in Necrotizing Skin infections Treatment Business (2016-2021)
Figure 59. Merck (Cubist Pharmaceutical) Revenue Growth Rate in Necrotizing Skin infections Treatment Business (2016-2021)
Figure 60. Wockhardt Revenue Growth Rate in Necrotizing Skin infections Treatment Business (2016-2021)
Figure 61. Atox Bio Revenue Growth Rate in Necrotizing Skin infections Treatment Business (2016-2021)
Figure 62. Basilea Pharmaceutical Revenue Growth Rate in Necrotizing Skin infections Treatment Business (2016-2021)
Figure 63. Melinta Therapeutics Revenue Growth Rate in Necrotizing Skin infections Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---